.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

It’s the much-anticipated Part II of our “What Does it Take” series (insert glorious trumpet announcement sound here).

Quantitation of Insulin Glargine and Major Metabolites in Human Plasma Using Hybrid LBA-LC/MS with Automated Magnetic Particle Processing

Impact of Plasma Hemolysis on the Recovery of Phenprocoumon in LC-MS/MS Chiral Assay

A Strategy for Maintaining Chromatographic Peak Shape Due to Incompatible Extract and Mobile Phase by LC-MS/MS

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

Last week we talked about our awesome lab staff who are responsible for sample collection and processing during a clinical trial.

Protein Quantitation Workflows using the TripleTOF 6600: A Case Study for Rituximab

Recruiting volunteers for a clinical trial is vital to its success, but once volunteers are in house it’s paramount to retain them through the length of the study. This could be one night or it could be weeks. Also, there could be one in-house period or several where the volunteer must return to the clinic again and again for several over-night stays.

So, the question as a clinical research site is, how do we keep our study volunteers happy and retain them for the length of the trial?

Comparison of Bottom-Up and Top-Down Analytical Methodologies for the Quantitative Bioanalysis of Large Therapeutic Peptides in Biological Matrix

Method Development of an Automated Hybrid LBA-LC/MS Assay for the Quantitative Bioanalysis of the Biotherapeutic Teriparatide in Human Plasma

A Phase IB Clinical Study to Evaluate the Analgesic Effect of GIC-1001 And GIC-1002 on Visceral Pain Under Rectal Distension Using the Barostat Method in Healthy Volunteers

Subscribe to